1 2 9 3 a r t I C l e S Nicotine is a powerful psychoactive drug inducing an addiction that kills about five million people per year as consequence of the noxious effects of tobacco smoke 1 . In addition, nicotine elicits taste and smell sensations and, at increasing concentrations, it produces strong burning, stinging and pain 2 . Notably, all variants of smokingcessation therapies that are based on nicotine replacement produce local irritation side effects 1, 3, 4 , which has been suggested to reduce treatment compliance and efficacy 5 . It is currently assumed that the irritant effects of nicotine are exclusively mediated by nAChRs expressed in nerve fibers that convey painful stimuli from the skin and mucosa [6] [7] [8] . However, some observations are not completely consistent with nAChRs being the sole targets of nicotine. For example, nAChRs quickly desensitize under the high local concentrations of nicotine used in replacement therapies (up to 60 mM), but the irritating effects of nicotine are long lasting.
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Nicotine is a powerful psychoactive drug inducing an addiction that kills about five million people per year as consequence of the noxious effects of tobacco smoke 1 . In addition, nicotine elicits taste and smell sensations and, at increasing concentrations, it produces strong burning, stinging and pain 2 . Notably, all variants of smokingcessation therapies that are based on nicotine replacement produce local irritation side effects 1, 3, 4 , which has been suggested to reduce treatment compliance and efficacy 5 . It is currently assumed that the irritant effects of nicotine are exclusively mediated by nAChRs expressed in nerve fibers that convey painful stimuli from the skin and mucosa [6] [7] [8] . However, some observations are not completely consistent with nAChRs being the sole targets of nicotine. For example, nAChRs quickly desensitize under the high local concentrations of nicotine used in replacement therapies (up to 60 mM) , but the irritating effects of nicotine are long lasting.
The TRP superfamily of cation channels is important in chemical nociception [9] [10] [11] , but no TRP channel has been shown to be directly activated by nicotine. However, nicotine seems to modulate the activity of the vanilloid receptor TRPV1, sensitizing it to capsaicin stimulation 12 and desensitizing it after nicotine-induced activation of nAChRs in sensory neurons 13 . We found that nicotine actually inhibited hTRPV1 (Supplementary Fig. 1 ), indicating that TRPV1 is not directly involved in the irritation caused by nicotine.
The emerging role of the ankyrin-rich channel TRPA1 as a broadly tuned chemosensor 14 prompted us to test whether this channel contributes to the irritating effects of nicotine. TRPA1 is expressed in a subset of polymodal nociceptive neurons 15 , determines behavioral responses to noxious cold 16 and to multiple irritant substances such as mustard oil (allyl isothiocyanate) 17, 18 and the unsaturated aldehydes contained in cigarette smoke 19 , and is involved in inflammatory pain 20, 21 . We found that TRPA1 is activated by nicotine and is crucial for the airway constriction reflex caused by application of this compound to the nasal mucosa.
RESULTS

Nicotine activates TRPA1
Extracellular application of nicotine to mTRPA1-expressing Chinese hamster ovary (CHO) cells induced a reversible increase of currents ( Fig. 1a-c) , which was not observed in control cells ( Supplementary  Fig. 2) . Stimulation with the nicotine analog anabasine induced a very similar mTRPA1 current activation (Supplementary Fig. 3 ). Fig. 4 ) and Fura-2-based measurements of the intracellular Ca 2+ concentration ( Supplementary Fig. 5 ) further confirmed that nicotine activated mTRPA1. In addition, nicotine activated hTRPA1 that we transfected into CHO cells (Supplementary Fig. 2 ).
Cell-attached patch-clamp recordings (Supplementary
We consistently found that the magnitude of the nicotine-activated TRPA1 current declined above ~300-1,000 µM, particularly at positive potentials (Fig. 1b-d) . Notably, the inhibitory effect reversed much faster than the activating effect, which explains the current rebound observed on washout of high doses of nicotine. This differential kinetics allowed us to dissect the activating and inhibitory effects of nicotine (Supplementary Fig. 6 ), yielding a maximal relative current increase of 4.0 ± 0.3 and 2.7 ± 0.2 at −75 and +50 mV, a r t I C l e S respectively, and the concentrations for half-maximal activation (EC 50 ; Fig. 1e ) and half-maximal inhibition (IC 50 ; Fig. 1e) .
As the response to nicotine occurred with a notable delay in wholecell (Fig. 1a-c) and cell-attached ( Supplementary Fig. 4 ) patch-clamp experiments, as well as in intracellular Ca 2+ -imaging experiments (Supplementary Fig. 5 ), we predicted that nicotine acts indirectly on the channel via a mechanism involving other membrane receptors and/or intracellular signaling pathways. To investigate this possibility, we tested the action of nicotine application to the intracellular side of the membrane in cell-free inside-out patches in the absence of extra-and intracellular Ca 2+ . Under this condition, 1 mM nicotine was still able to activate single mTRPA1 channels. These channels had a conductance of 112 ± 8 pS at −75 mV (n = 5) and were reversibly blocked by 1 mM menthol (Fig. 2) , consistent with previous studies [22] [23] [24] [25] [26] . Notably, nicotine-induced activation was substantially faster in inside-out patches than in whole-cell recordings. This indicates that the delay in TRPA1 activation on extracellular application of nicotine reflects, at least partly, the rate of nicotine diffusion across the plasma membrane. Nicotine caused a significant reduction of the single channel conductance at positive potentials, from 114 ± 7 pS in controls to 80 ± 6 pS in the presence of 1 mM nicotine (n = 5, P = 0.004). Taken together, these data indicate that nicotine interacts with TRPA1 in a membrane-delimited manner.
Activation of TRPA1 by electrophiles, such as mustard oil, cinnamaldehyde and acrolein, involves covalent modification of N-terminal cysteine residues 27, 28 . Thus, we tested nicotine's effect on an mTRPA1 mutant in which the critical cysteine residue C622 is mutated to serine. Consistent with previous work 27, 28 , this mutant was unresponsive to mustard oil (20 µM), but was activated by 1 mM nicotine (Supplementary Fig. 7 ). These results indicate that nicotine-induced Outward Inward a a r t I C l e S activation does not involve modification of cysteine 622, which is fully in accordance with the nonelectrophilic character of nicotine. Activation of TRPA1 by other nonelectrophilic chemicals, such as menthol, clotrimazole and nifedipine, or by cold temperatures involves a shift of the voltage dependence of channel activation toward negative voltages 23, 25, 26 . To examine whether nicotine acts in a similar manner, we applied a voltage-step protocol that allowed us to assess the voltage dependence of activation from the measurement of peak tail currents. In these experiments, Ca 2+ was omitted from the extracellular solution and 2 mM EDTA was added to avoid any interference of Ca 2+ ions with the effect of nicotine on TRPA1 activation 29, 30 . In the absence of nicotine, clear tail currents were only observed at prepulse potentials greater than +50 mV ( Supplementary Fig. 8 ). In the presence of 300 µM nicotine, tail currents were already obvious at prepulse potentials above 0 mV. We fitted average tail currents in the presence of 300 µM nicotine with a Boltzmann function (see Online Methods), which yielded a voltage for half maximal activation (V act ) of 162 ± 4 mV and a slope factor (s act ) of 36.9 ± 1.5 mV. In the absence of nicotine, tail currents were far from saturation at the most depolarizing prepulse potentials (+200 mV), which precluded the accurate independent estimation of V act or s act . However, assuming a constant s act , the nicotine-induced changes in tail currents can be accounted for by a 51-mV shift of the activation curve toward negative voltages ( Supplementary Fig. 8 ). In principle, such a leftward shift of the activation curve can be a result of a stabilization of the open state, a destabilization of the closed state or both. We observed that nicotine decreased the rate of whole-cell current deactivation at negative voltages and increased the rate of activation and very positive potentials ( Supplementary Fig. 8 ). This is consistent with an increased mean open time and a reduced mean close time in the presence of nicotine ( Supplementary Fig. 4 ).
Oral application of mustard oil is known to prevent later stimulation with other irritant chemicals including nicotine, a phenomenon known as cross-desensitization 31 . Thus, we tested whether nicotineinduced activation of TRPA1 influences the effect of mustard oil and vice versa. Indeed, pre-activation with 100 µM nicotine significantly blunted (P < 0.01) a subsequent response to 100 µM mustard oil (Fig. 3) . Conversely, pre-activation of mTRPA1 with mustard oil fully a r t I C l e S abolished the response to nicotine. These data indicate that the sensory cross-desensitization between mustard oil and nicotine occurs, at least partly, at the level of the chemosensor TRPA1.
Inhibition of TRPA1 by the nAChR blocker mecamylamine
The mechanisms of nicotine-induced irritation have been extensively studied in several animal models and in humans. Notably, from the effects of mecamylamine, a general inhibitor of nAChRs, several studies have suggested that nAChRs are involved in nicotine-induced irritation 2,7,32 . However, reduction of the irritation caused by application of high concentrations of nicotine requires prolonged pre-application of mecamylamine at concentrations that are much higher than those needed to fully inhibit nAChRs in vitro (1-5 mM versus 30-100 µM, respectively) 7, 32, 33 . Because mecamylamine has structural similarities with camphor, a known inhibitor of TRPA1 (ref. 34) , we hypothesized that it may also inhibit TRPA1, which would account, at least in part, for its inhibitory effect on the irritation caused by nicotine at high concentrations. We found that mecamylamine prevented the mustard oil-induced activation of mTRPA1 current with almost total inhibition at 5 mM (Fig. 4a-c) . These experiments were repeated and the results confirmed in intact mTRPA1-expressing CHO cells (Fig. 4d) and cultured mouse trigeminal ganglion neurons (Fig. 4e) .
In addition, mecamylamine inhibited mTRPA1 currents pre-activated by mustard oil and nicotine (Supplementary Fig. 9 ) and the human TRPA1 ortholog (Supplementary Fig. 10 ). Consequently, we tested whether TRPA1 is modulated by hexamethonium, a mecamylamine-unrelated nAChR inhibitor that has been widely used to assess the role of these receptors in the irritating effects of cigarette smoke 8 . In contrast with mecamylamine, hexamethonium did not substantially affect basal TRPA1 currents (Fig. 4f,g ), nor did it prevent TRPA1 activation by mustard oil in mTRPA1-expressing CHO cells (Fig. 4f-h ) and trigeminal ganglion neurons (Fig. 4i) . Hence, hexamethonium is a better tool than mecamylamine for selectively inhibiting nAChRs without interfering with mTRPA1.
TRPA1-mediated response to the nicotine in sensory neurons
We next tested whether TRPA1 contributes to the sensory responses to nicotine in mouse trigeminal ganglion neurons. In contrast with earlier in vitro studies 13, 35, 36 , we considered the relatively high EC 50 and slow onset of nicotine effects on TRPA1 (see above) and tested the effect of long (2 min) applications of nicotine at 100 µM and 1 mM. Exposure to 100 µM nicotine caused a significant increase (P < 0.01) in the intracellular Ca 2+ concentration in ~10% (29 out of 298) of wild-type trigeminal ganglion neurons (Fig. 5) . All of the nicotine-responsive cells were sensitive to capsaicin and 90% were a r t I C l e S also activated by 100 µM mustard oil, indicating that they were nociceptive neurons. In contrast, a significantly lower proportion of Trpa1 knockout neurons (4%, 11 out of 262, P = 0.011) responded to 100 µM nicotine. Application of 1 mM nicotine activated 23% (88 out of 383) of wild-type trigeminal ganglion neurons; about 72% of these neurons also responded to 100 µM mustard oil (Fig. 5b,e) . Again, the fraction of nicotine-sensitive cells was significantly reduced in Trpa1 knockout mice (12%, 40 out of 320, P = 0.00034; Fig. 5c,e) . Nicotine was able to trigger strong responses in wild-type neurons in the presence of the nAChR blocker hexamethonium (15%, 48 out of 311; Fig. 5d) , which, as shown above, did not affect TRPA1. These responses were restricted to the mustard oil-sensitive neuronal population (Fig. 5e) . Notably, only 4 out of 257 Trpa1 knockout neurons responded to 1 mM nicotine in the presence of hexamethonium (<1.6%, significantly lower than in wild type, P = 10 −8 ; Fig. 5e ), which indicates that the vast majority (presumably >93%) of the responses in wild-type mice are mediated by nAChRs and/or TRPA1. Notably, the responses to nicotine in TRPA1-expressing (mustard oil sensitive) neurons were characterized by a broad distribution of the time to maximal increase (time to peak) and recovery occurred only after washout of nicotine (Fig. 5a,b,d,f) . In contrast, in TRPA1-negative neurons, the large majority of the responses (88% in nicotine 1 mM) reached the maximum before 1 min and all of them decayed in the presence of nicotine (desensitized) within 2 min (Fig. 5a,b,c,f) . In addition, whole-cell patch-clamp recordings in mouse trigeminal neurons revealed the presence of TRPA1-like and nAChR-like responses to extracellular nicotine application (Supplementary Fig. 2 ).
TRPA1 mediates the nasal irritation induced by nicotine
To test whether TRPA1 contributes to the known irritant effects of nicotine in vivo, we compared the airway constriction reflexes of wildtype and Trpa1 knockout mice to stimulation of the nasal mucosa 37 . To monitor the respiratory function before and after nasal instillation of test solutions, we used unrestrained whole-body plethysmography and used the increase in enhanced pause (Penh) as a measure of airway constriction 38 . Penh significantly increased (P = 0.027) above control levels after application of nicotine in wild-type, but not in Trpa1 knockout mice (P = 1; Fig. 6a) . Instillation of vehicle alone had no effect on Penh (Fig. 6b) , whereas instillation of mustard oil selectively increased Penh in wild-type mice (Fig. 6c) . Trpa1 knockout mice showed normal responses to increasing concentrations of aerosolized methacholine, a muscarinic receptor agonist causing contraction of airway smooth muscle cells 38 (Fig. 6d) .
Menthol is popularly used as an additive in nicotine-containing products to produce cooling, soothing and analgesic effects, which are thought to counteract the irritation caused by tobacco smoke 39 and nicotine 40 . It was therefore interesting to determine the effects of this compound on the TRPA1-mediated responses to nicotine. Extracellular application of 100 µM menthol caused a significant reduction in mTRPA1 currents prestimulated with 100 µM nicotine (60 ± 7% at −75 mV, P = 10 −4 ; n = 6; Fig. 7a ) and reversed the increase in intracellular Ca 2+ concentration induced by 1 mM nicotine in mTRPA1-expressing CHO cells (Fig. 7b) . Notably, nasal instillation of a menthol (10 mM) and nicotine (60 mM) mixture triggered a smaller Penh response than the instillation of nicotine alone (Fig. 7c) , suggesting that menthol reduces the airway constriction reflex triggered by nicotine. The Penh response to instillation of menthol alone (10 mM) was similar to that obtained with vehicle ( Supplementary Fig. 11 ). This result is consistent with a previous report that menthol causes oral trigeminal stimulation in rats only at concentrations above 32 mM (ref. 41) .
DISCUSSION
It has been generally thought that the irritating effect of nicotine is exclusively mediated by nAChRs expressed in nociceptive nerves fibers [6] [7] [8] 32 . In contrast, we found that nicotine caused irritation via activation of TRPA1, a cation channel involved in the transduction of noxious chemical stimuli. First, we found that nicotine stimulates heterologously expressed TRPA1, acting as a gating modifier. Second, we identified TRPA1-mediated nicotine responses in a subset of nociceptive neurons. These responses could be clearly distinguished from those mediated by nAChRs on the basis of their dose dependence, kinetics and pharmacological profile. Finally, we found that TRPA1 Instillation a r t I C l e S was necessary for the nicotine-induced airway constriction reflex in mice. To the best of our knowledge, this is the first demonstration of the in vitro and in vivo activation of a TRP channel by nicotine.
We found that nicotine actually had a bimodal action on TRPA1, with activation and inhibition occurring at low and high concentrations, respectively. As the inhibitory effect reversed much faster than the activating effect, a prominent current rebound was observed on washout of higher doses of nicotine. The effect of nicotine is reminiscent of that of menthol and menthol-related compounds, for which a bimodal action on the mouse TRPA1 clone has also been reported 23, 24 . Using a mutagenesis approach based on the differences in menthol sensitivity of various TRPA1 orthologs, a previous study identified residues in the putative S5 segment as determinants for the stimulatory effect 24 . The study found that menthol's ability to inhibit mouse TRPA1, but not human TRPA1, is determined by specific amino acids distributed all across the putative pore domains. Our data suggest that nicotine interacts with the pore, as application of 1 mM nicotine induced a ~30% reduction of the single-channel conductance at positive potentials. Moreover, the fast relief of inhibition on nicotine washout is consistent with a binding site in the pore, which is quickly accessible from the extracellular solution. A bimodal effect has also been reported for 2-aminoethoxydiphenyl borate on TRPV3 (ref. 42) , with an abrupt, but transient, increase in current on washout of high doses of the agonist.
It is well known that prior oral stimulation with the epitomic TRPA1-agonist mustard oil reduces the sensitivity to other irritant chemicals, such as nicotine 31 . Our data suggest that this cross-desensitization arises at the level of the common chemoreceptor, TRPA1. Indeed, we found that prior stimulation of TRPA1 by mustard oil fully abolished a later response to nicotine. Conversely, prior stimulation with nicotine led to a reduction of the mustard oil response. In this respect, it should be noted that nicotine and mustard oil have similar EC 50 values for activating inward TRPA1 currents (17 and 11 µM, respectively), but that mustard oil is a much more effective activator, producing up to a 30-fold current increase, as compared with the maximal fivefold increase in inward current caused by nicotine (Fig. 3) .
Activation of TRPA1 by electrophiles, such as mustard oil, cinnamaldehyde and acrolein, occurs through covalent modification of cysteine residues on the channel 27, 28 . We were able to exclude the possibility that nicotine acts via a similar mechanism, as we found that the mustard oil-insensitive mutant C622S (ref. 28) can be readily activated by nicotine, which is consistent with the nonelectrophilic nature of nicotine. Thus, we consider it most likely that nicotine acts on TRPA1 through a noncovalent interaction with the channel, similar to the actions of other nonelectrophilic agonists, such as icilin 15 , menthol 23, 24 , clotrimazole 25 and nifedipine 26 . Indeed, as has been reported for the latter three compounds, nicotine caused a negative shift in the voltage dependence of channel activation. In addition, we found that nicotine reduced the rate of whole-cell current deactivation and accelerated activation. These observations are fully consistent with our observations of a negative shift of the voltage dependence of channel activation and an increase in the mean open time and reduction of the mean closed time of single TRPA1 channels. Thus, nicotine causes both stabilization of the open conformation and destabilization of the closed conformation of TRPA1.
Our experiments in mouse trigeminal ganglion neurons strongly support the role of TRPA1 as mediator of nicotine-induced irritation. First, nicotine activated a subset of neurons that largely overlaps with the TRPA1-expressing (mustard oil sensitive) population. Second, the proportion of nicotine-sensitive neurons was strongly reduced in Trpa1 knockout mice. Third, nicotine elicited robust responses in the presence of the specific nAChRs inhibitor hexamethonium. Fourth, nicotine responses were virtually abolished in Trpa1 knockout mice neurons in the presence of hexamethonium. Finally, the responses to nicotine in TRPA1-expressing (mustard oil sensitive) neurons were kinetically different from the responses in TRPA1-negative (mustard oil insensitive) neurons. Thus, we conclude that nicotine evokes two distinct types of responses in wild-type trigeminal ganglion neurons: rapid and quickly desensitizing responses mediated by nAChRs and slower, more sustained responses mediated by TRPA1.
Our results prompt a re-evaluation of the mechanisms underlying the irritating effects of nicotine by introducing TRPA1 as a previously unknown ionotropic nicotine receptor that is distinct from nAChRs. On the one hand, the mucosal nicotine concentrations attained during tobacco smoke exposure are submicromolar 43 and are therefore lower than those necessary to activate TRPA1. Thus, the reported acute irritant effects of nicotine delivered in this way are probably mediated by nAChRs 8 . However, many studies aimed at understanding the irritating effects of nicotine on mucosal irritation in vivo have used millimolar concentrations of nicotine, as high as 600 mM 7, 32, 44 . Moreover, in many instances the inhibition of nicotineinduced responses by mecamylamine has been taken as evidence for the involvement of nAChRs. Our current data challenge this view, as we found that TRPA1 was not only activated by nicotine, but was also inhibited by mecamylamine.
To test the relevance of nicotine-induced activation of TRPA1 in vivo, we studied the irritating effects of nicotine on wild-type and Trpa1 knockout mice. We simulated the application of nicotine nasal sprays, which generally contain nicotine at concentrations around 60 mM, by studying the well-known airway constriction reflex to noxious stimulation of the nasal mucosa 37, 45 . Notably, this form of nicotine replacement therapy is the most effective one, but has the highest treatment dropout rate as a result of mucosal irritation 5 . Nasal instillation of nicotine provoked an increase of Penh, a surrogate measure of airway constriction, in wild-type, but not in Trpa1 knockout, mice. The normal response of Trpa1 knockout mice to the bronchoconstrictor methacholine indicates that the lack of nicotineand mustard oil-induced response in these mice is not caused by an unspecific contractile dysfunction of the airway smooth muscle. Altogether, these results indicate that TRPA1 mediates the irritating effect of nasal nicotine instillation. Notably, it is apparent from our data that nAChRs did not contribute to the airway constriction reflex, which contrasts with the observation of nAChR-like responses in primary cultured trigeminal ganglion neurons. This disagreement could be explained by the transient character of nAChR activation, which may have hindered the contribution of nAChRs to the airway constriction reflex in our in vivo experimental model. Alternatively, the sensory neurons that respond to nicotine via activation of nAChRs may not be involved in the long-lasting airway reflex following nicotine stimulation of the nasal mucosa.
We found that menthol, a known blocker of mouse TRPA1, induced an inhibition of mouse TRPA1 currents that were pre-activated by nicotine and reduced the Penh response on intranasal instillation of nicotine in mice. Caution should be taken, however, when trying to extrapolate the effects of menthol to humans, as this compound does not inhibit human TRPA1 (ref. 24) . The well-known soothing effect of menthol in tobacco-containing products 39 may well be related to activation of TRPM8, which has been shown to produce analgesia 46 . Nevertheless, our results indicate that inhibition of TRPA1 represents an interesting approach for developing smoking cessation therapies with less adverse effects. a r t I C l e S Our findings are also relevant to the ecological role and industrial uses of nicotine and its analog anabasine, which are known to be strong repellents of herbivores. Notably, Brassicaceae and Nicotiana plants increase their production of either isothiocyanates 47 or nicotine and anabasine 48 , respectively, following herbivore attack. This suggests that the promiscuous character of TRPA1 chemo-activation underlies a unified mechanism for the detection of a wide range of noxious compounds that function as botanical defensive traits.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
